Bethea A. Kleykamp
University of Maryland, Baltimore
ORCID: 0000-0001-7117-0507Also affiliated with Georgetown University, American Society of Addiction Medicine
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 5 papers. Top paper: “ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids”.
Andrew A. Herring, Sarah S. Kawasaki, Marjorie Meyer, Bethea A. Kleykamp, Kelly S. Ramsey +1 more
Bethea A. Kleykamp, Sandra D. Comer, Roland R. Griffiths, Andrew S. Huhn, Matthew W. Johnson +22 more
Katherine J. Holzer, Robert D. Kerns, Christin Veasley, Robert H. Dworkin, Dennis C. Turk +32 more
Dan Cherkin, Andrew S.C. Rice, Robert H. Dworkin, Dennis C. Turk, Michael P. McDermott +33 more
Kyle J. Walters, Andreana Benitez, Rachel L. Tomko, Bethea A. Kleykamp, Erin A. McClure +1 more